Press and Media
Lifespin partners with the Leipzig Research Center for Civilization Diseases (LIFE) to obtain deep clinical insights for obesity and diabetes
8,000 patient samples to be digitized and studied for metabolic patterns
Lifespin Announces Inaugural Membership in the Industrial Participant Program of the Wyss Diagnostics Accelerator at Harvard University
Wyss Diagnostics Accelerator seeks to fast-track disruptive diagnostic technologies to meet unmet critical needs
Lifespin Granted ISO13485 Certification for Its Proprietary A.I.-based Metabolomics Platform for In Vitro Diagnostics
ISO13485 certification represents a key milestone towards achieving market-readiness of its automated, high-volume testing infrastructure and ability to build affordable and scalable omics-based precision medicine ...